The BCL-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect With Dexamethasone and Melphalan

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1526
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search